200 related articles for article (PubMed ID: 16754682)
1. Surfactant protein A directly interacts with TLR4 and MD-2 and regulates inflammatory cellular response. Importance of supratrimeric oligomerization.
Yamada C; Sano H; Shimizu T; Mitsuzawa H; Nishitani C; Himi T; Kuroki Y
J Biol Chem; 2006 Aug; 281(31):21771-21780. PubMed ID: 16754682
[TBL] [Abstract][Full Text] [Related]
2. Interaction of soluble form of recombinant extracellular TLR4 domain with MD-2 enables lipopolysaccharide binding and attenuates TLR4-mediated signaling.
Hyakushima N; Mitsuzawa H; Nishitani C; Sano H; Kuronuma K; Konishi M; Himi T; Miyake K; Kuroki Y
J Immunol; 2004 Dec; 173(11):6949-54. PubMed ID: 15557191
[TBL] [Abstract][Full Text] [Related]
3. Recombinant soluble forms of extracellular TLR4 domain and MD-2 inhibit lipopolysaccharide binding on cell surface and dampen lipopolysaccharide-induced pulmonary inflammation in mice.
Mitsuzawa H; Nishitani C; Hyakushima N; Shimizu T; Sano H; Matsushima N; Fukase K; Kuroki Y
J Immunol; 2006 Dec; 177(11):8133-9. PubMed ID: 17114488
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary surfactant protein D inhibits lipopolysaccharide (LPS)-induced inflammatory cell responses by altering LPS binding to its receptors.
Yamazoe M; Nishitani C; Takahashi M; Katoh T; Ariki S; Shimizu T; Mitsuzawa H; Sawada K; Voelker DR; Takahashi H; Kuroki Y
J Biol Chem; 2008 Dec; 283(51):35878-88. PubMed ID: 18990700
[TBL] [Abstract][Full Text] [Related]
5. Mannose binding lectin and lung collectins interact with Toll-like receptor 4 and MD-2 by different mechanisms.
Shimizu T; Nishitani C; Mitsuzawa H; Ariki S; Takahashi M; Ohtani K; Wakamiya N; Kuroki Y
Biochim Biophys Acta; 2009 Dec; 1790(12):1705-10. PubMed ID: 19840833
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 4 region Glu24-Lys47 is a site for MD-2 binding: importance of CYS29 and CYS40.
Nishitani C; Mitsuzawa H; Sano H; Shimizu T; Matsushima N; Kuroki Y
J Biol Chem; 2006 Dec; 281(50):38322-9. PubMed ID: 17056597
[TBL] [Abstract][Full Text] [Related]
7. Human pulmonary surfactant protein D binds the extracellular domains of Toll-like receptors 2 and 4 through the carbohydrate recognition domain by a mechanism different from its binding to phosphatidylinositol and lipopolysaccharide.
Ohya M; Nishitani C; Sano H; Yamada C; Mitsuzawa H; Shimizu T; Saito T; Smith K; Crouch E; Kuroki Y
Biochemistry; 2006 Jul; 45(28):8657-64. PubMed ID: 16834340
[TBL] [Abstract][Full Text] [Related]
8. Serum amyloid A3 binds MD-2 to activate p38 and NF-κB pathways in a MyD88-dependent manner.
Deguchi A; Tomita T; Omori T; Komatsu A; Ohto U; Takahashi S; Tanimura N; Akashi-Takamura S; Miyake K; Maru Y
J Immunol; 2013 Aug; 191(4):1856-64. PubMed ID: 23858030
[TBL] [Abstract][Full Text] [Related]
9. sTLR4/MD-2 complex inhibits colorectal cancer in vitro and in vivo by targeting LPS.
Zou Y; Qin F; Chen J; Meng J; Wei L; Wu C; Zhang Q; Wei D; Chen X; Wu H; Chen X; Dai S
Oncotarget; 2016 Aug; 7(32):52032-52044. PubMed ID: 27409669
[TBL] [Abstract][Full Text] [Related]
10. Flavonoids from Radix Tetrastigmae inhibit TLR4/MD-2 mediated JNK and NF-κB pathway with anti-inflammatory properties.
Liu D; Cao G; Han L; Ye Y; SiMa Y; Ge W
Cytokine; 2016 Aug; 84():29-36. PubMed ID: 27235587
[TBL] [Abstract][Full Text] [Related]
11. Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner.
Honda H; Nagai Y; Matsunaga T; Saitoh S; Akashi-Takamura S; Hayashi H; Fujii I; Miyake K; Muraguchi A; Takatsu K
J Leukoc Biol; 2012 Jun; 91(6):967-76. PubMed ID: 22422925
[TBL] [Abstract][Full Text] [Related]
12. Role of the degree of oligomerization in the structure and function of human surfactant protein A.
Sánchez-Barbero F; Strassner J; García-Cañero R; Steinhilber W; Casals C
J Biol Chem; 2005 Mar; 280(9):7659-70. PubMed ID: 15615713
[TBL] [Abstract][Full Text] [Related]
13. [Effect of sophoridine and TLR4/MD-2 blocking agent on pathway of LPS-induced RAW264. 7 macrophage TLR4-NF-kappaB-TNF-alpha].
Wang YR; Yang F; Liu J; Zhou Y
Zhongguo Zhong Yao Za Zhi; 2012 Oct; 37(20):3107-11. PubMed ID: 23311163
[TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2.
Rallabhandi P; Phillips RL; Boukhvalova MS; Pletneva LM; Shirey KA; Gioannini TL; Weiss JP; Chow JC; Hawkins LD; Vogel SN; Blanco JC
mBio; 2012; 3(4):. PubMed ID: 22872782
[TBL] [Abstract][Full Text] [Related]
15. Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF-alpha secretion are down-regulated by lung collectin surfactant protein A.
Sato M; Sano H; Iwaki D; Kudo K; Konishi M; Takahashi H; Takahashi T; Imaizumi H; Asai Y; Kuroki Y
J Immunol; 2003 Jul; 171(1):417-25. PubMed ID: 12817025
[TBL] [Abstract][Full Text] [Related]
16. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
[TBL] [Abstract][Full Text] [Related]
17. A toll-like receptor-4-interacting surfactant protein-A-derived peptide suppresses tumor necrosis factor-α release from mouse JAWS II dendritic cells.
Awasthi S; Brown K; King C; Awasthi V; Bondugula R
J Pharmacol Exp Ther; 2011 Mar; 336(3):672-81. PubMed ID: 21159752
[TBL] [Abstract][Full Text] [Related]
18. Identification of synthetic peptides that inhibit lipopolysaccharide (LPS) binding to myeloid differentiation protein-2 (MD-2).
Yan H; Gu CG; Xu FL; Wu XH; Yin HH; Hu CX; Zhu XD; Liu F; Ge HJ; Chen LY; Zhang XY; Wang ZG; Xing Z; Li L
J Immunother; 2013 Apr; 36(3):197-207. PubMed ID: 23502767
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of endotoxin responses is achieved by targeting the TLR4 coreceptor, MD-2.
Visintin A; Halmen KA; Latz E; Monks BG; Golenbock DT
J Immunol; 2005 Nov; 175(10):6465-72. PubMed ID: 16272300
[TBL] [Abstract][Full Text] [Related]
20. Surfactant protein A inhibits peptidoglycan-induced tumor necrosis factor-alpha secretion in U937 cells and alveolar macrophages by direct interaction with toll-like receptor 2.
Murakami S; Iwaki D; Mitsuzawa H; Sano H; Takahashi H; Voelker DR; Akino T; Kuroki Y
J Biol Chem; 2002 Mar; 277(9):6830-7. PubMed ID: 11724772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
